Meridiem Capital Partners LP Abbott Laboratories Transaction History
Meridiem Capital Partners LP
- $1.56 Trillion
- Q3 2025
A detailed history of Meridiem Capital Partners LP transactions in Abbott Laboratories stock. As of the latest transaction made, Meridiem Capital Partners LP holds 94,027 shares of ABT stock, worth $12.2 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
94,027
Previous 247,189
61.96%
Holding current value
$12.2 Million
Previous $33.6 Billion
62.54%
% of portfolio
0.8%
Previous 2.37%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,652Shares Held
1.38BCall Options Held
10.3MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...